Deep Dive: Digital Health

There’s so much happening in digital health right now that we could probably run an issue of Deep Dive on it every month. With innovations coming thick and fast, it’s important that pharma focuses in on the innovations that will have a meaningful impact on their organisations and the patients they serve.

It’s fair to say that AI has been one of the most talked-about technology revolutions of the past five years, and we’ve recruited several experts to tell us exactly how it may impact pharma.

Our own Richard Staines runs through the latest news in AI for pharma R&D, and Paul Tunnah speaks with IBM Watson’s Christina Busmalis for a broader view of the technology. Meanwhile, Matthew Van Wingerden and Pini Ben-Or from Aktana tell us what true AI should actually look like and how it can be applied to commercial teams.

But while AI might be the most headline-grabbing technology at the moment, there are still thousands of other digital health innovations being worked on, many of which also have the potential to change healthcare and pharma as we know it.

Elsewhere in this issue, Matt Lowe from performance.io tells us why pharma is lacking in its performance marketing efforts, based on techniques such as search engine optimisation (SEO); we speak to Roche Diabetes Care’s Michael Goetzl about combined digital-pharmaceutical approaches to diseases; and we have an exclusive interview with Almirall’s chief digital office Francescsa Wuttke, who is looking to completely transform her organisation’s approach to digital and foster startups that the company can learn from.

I hope you enjoy the issue.

Kind regards,
George

George Underwood – Editor, Deep Dive: Digital Health